Search

everythinglearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Ayurveda-based care with Guduchi, Ashwagandha, and Curcumin improved quality of life for breast cancer patients without serious side effects.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Fasting may reduce chemotherapy side effects.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Hypertrichosis lanuginosa causes excessive fine hair growth, often linked to genetics or cancer, with limited treatment options.

Different types of long-lasting stem cells are responsible for the growth and upkeep of the mammary gland.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.